Design and synthesis of S-(-)-2-[[4-(napht-1-yl)piperazin-1-yl]methyl]-1,4-dioxoperhydropyrrolo[1,2-a]pyrazine (CSP-2503) using computational simulation. A 5-HT1A receptor agonist

Bioorg Med Chem Lett. 2003 Apr 17;13(8):1429-32. doi: 10.1016/s0960-894x(03)00160-4.

Abstract

Based on a computational model for 5-HT(1A)R-ligand interaction and QSAR studies, we have designed and synthesized a new series of arylpiperazines 2-8 which exhibit high 5-HT(1A)R affinity and selectivity over alpha(1)-adrenergic receptors. Among them, compound CSP-2503 (4) has been pharmacologically characterized as a 5-HT(1A)R agonist at somatodendritic and postsynaptic sites, endowed with anxiolytic properties.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Anti-Anxiety Agents / chemical synthesis
  • Anti-Anxiety Agents / pharmacology
  • Benzene Derivatives / chemistry
  • Benzene Derivatives / metabolism
  • Benzene Derivatives / pharmacology
  • Body Temperature / drug effects
  • Computer Simulation
  • Dose-Response Relationship, Drug
  • Drug Design
  • HeLa Cells
  • Humans
  • Mice
  • Models, Molecular
  • Piperazines / chemical synthesis*
  • Piperazines / chemistry
  • Piperazines / metabolism
  • Piperazines / pharmacology*
  • Pyrazines / chemical synthesis
  • Pyrazines / chemistry
  • Pyrazines / pharmacology
  • Quantitative Structure-Activity Relationship
  • Receptors, Adrenergic, alpha-1 / metabolism
  • Receptors, Serotonin, 5-HT1 / drug effects*
  • Receptors, Serotonin, 5-HT1 / metabolism
  • Serotonin Receptor Agonists / chemical synthesis*
  • Serotonin Receptor Agonists / chemistry
  • Serotonin Receptor Agonists / metabolism
  • Serotonin Receptor Agonists / pharmacology*
  • Synaptic Transmission / drug effects

Substances

  • 2-((4-(naphth-1-yl)piperazin-1-yl)methyl)-1,4-dioxoperhydropyrrolo(1,2-a)pyrazine
  • Anti-Anxiety Agents
  • Benzene Derivatives
  • Piperazines
  • Pyrazines
  • Receptors, Adrenergic, alpha-1
  • Receptors, Serotonin, 5-HT1
  • Serotonin Receptor Agonists